Mengzhao Xun

Mengzhao Xun

Auto-generated profile, based on publicly available information

Mengzhao Xun

ENT Institute and Department of Otorhinolaryngology, Eye and ENT Hospital Fudan University Shanghai China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
MXMengzhao Xun
Mengzhao Xun
XLXu Liu
Xu Liu
YSYongfang Sha
Yongfang Sha
XZXin Zhang
Xin Zhang
JLJian Ping Liu
Jian Ping Liu
Objective: The purpose of this meta‐analysis was to compare the efficiency of high‐resolution computed tomography (HRCT) and diffusion‐weighted magnetic resonance imaging (DWI) in guiding the diagnosis of middle ear cholesteatoma in clinical practice.Materials and methods: Cochrane Library, Medline, Embase, PubMed, and Web of Science were searched for studies that evaluated the sensitivity and specificity of HRCT or DWI in detecting middle ear cholesteatoma. A random‐effects model was used to calculate and summarize the pooled estimates of sensitivity, specificity, and diagnostic odds ratios. Postoperative pathological results were considered as the diagnostic gold standard for middle ear cholesteatoma.Results: Fourteen published articles (860 patients) met the inclusion criteria. The sensitivity and specificity of DWI when diagnosing cholesteatoma (regardless of type) were 0.88 (95% confidence interval [CI], 0.80–0.93) and 0.93 (95% CI, 0.86–0.97), respectively, while those of HRCT were 0.68 (95% CI, 0.57–0.77) and 0.78 (95% CI, 0.60–0.90), respectively. Notably, the sensitivity and specificity levels of DWI were similar to those of HRCT (p = .1178 for sensitivity, p = .2144 for specificity; pair‐sampled t tests). The sensitivity and specificity of DWI or HRCT for the diagnosis of primary cholesteatoma were 0.78 (95% CI, 0.65–0.88) and 0.84 (95% CI, 0.69–0.93), respectively, while that for recurrent cholesteatoma were 0.93 (95% CI, 0.61–0.99) and 0.94 (95% CI, 0.82–0.98), respectively.Conclusion: DWI and HRCT have similar levels of high sensitivity and specificity in detecting various cholesteatomas. Also, the diagnostic efficiency of HRCT or DWI for recurrent cholesteatoma is identical to that of primary cholesteatoma. Therefore, HRCT may be used in clinical settings to reduce the use of DWI and save clinical resources.Lay summary: Data on the use of diffusion‐weighted magnetic resonance imaging and high‐resolution computed tomography in the diagnosis of cholesteatoma were obtained through a literature search. They were analyzed to guide the clinical diagnosis and treatment of cholesteatoma.Level of evidence: NA

6 October 2025 in Molecular Therapy
Verified
Journal Article
Closed access
MXMengzhao Xun
Mengzhao Xun
XFXintai Fan
Xintai Fan
HWHui Wang
Hui Wang
JZJingjing Zhao
Jingjing Zhao
GTGongrui Tang
Gongrui Tang
YSYilai Shu
Yilai Shu